Workshop Outline and Objectives
Jermiah J. Joseph
Princess Margaret Cancer Centrejermiah.joseph@uhn.ca
18 October 2024
Source:vignettes/Workshop_Outline.Rmd
Workshop_Outline.Rmd
Course Description
This course explores the evolving field of personalized cancer treatment, focusing on tailoring treatment strategies to patients based on their unique molecular profiles. Participants will gain a comprehensive understanding of the field of pharmacogenomics and a guided workflow covering basic to advanced biomarker analysis. Our primary emphasis is on the analysis of cancer biomarkers; however, the principles and methodologies covered in this context are transferable and applicable to other disease areas.
The course is designed to provide sufficient context to beginners, building up from basics to tools and methods of data analysis. The hands-on practical tutorials for each session will provide the participants with practical insights into the data as well as tools to perform biomarker analysis on their own. By the end of this introductory course, participants will be equipped with the knowledge and skills to understand data requirements and perform biomarker analysis.
Course Objectives
Participants will gain practical experience and skills to be able to:
Extract features for biomarker discovery from -omics data (RNA-Seq, methylation, mutations, proteomics, chromatin profiling, etc) Navigate pharmacogenomics datasets and data preparation for pharmacogenomic analysis Identify univariable biomarkers from RNA-Seq data Perform meta-analysis to identify robust biomarkers Visualize and summarize the output of pharmacogenomic biomarker analysis
Prerequisites
Participants should be comfortable writing and reading basic R.
You will require your own laptop computer. Minimum requirements: 1024×768 screen resolution, 1.5GHz CPU, 4GB RAM, 20GB free disk space, recent versions of Windows, Mac OS X or Linux (Most computers purchased in the past 3-4 years likely meet these requirements).
This workshop requires participants to complete pre-workshop tasks and readings which includes installing and setting up an R environment.
Course Outline
Module 1: Introduction to Pharmacogenomics and Biomarker Discovery
Lecture:
- A brief introduction to precision oncology and biomarkers
- Overview to personalized cancer treatment and the role of biomarker discovery
- What is “pharmacogenomics”; is it different from pharmacogenetics?
- Challenges in biomarker discovery
- Brief introduction to biomarkers in pharmacogenomics
- Conventional markers: oncogenic mutations, gene expression, proteomics
- Exciting new fields: mutational signatures, synthetic lethality, chromatin accessibility
- Other markers like radiomic features
- Overview of methods for patient profiling
- Sequencing technologies: RNA-Seq, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), etc.
- Solid tumor vs liquid biopsy
Module 2: Data Preparation for Pharmacogenomic Analysis
Lecture:
- Common preclinical pharmacogenomic models and importance of clinical
validation
- Cell lines, patient-derived xenografts (PDX), organoids, etc.
- Importance of clinical validation in biomarker discovery
- What is in a typical pharmacogenomic dataset?: dataset overview using PharmacoGx
- Quality control: batch effects, outliers, missing values, and common sources of variation
Module 3: Pharmacogenomics for biomarker discovery – Basic analysis
Module 4: Pharmacogenomics for biomarker discovery – Advanced analysis
Lecture:
- Meta-analysis
- Introduction to “meta-analysis” in the context of inter-study investigations
- Visualization and interpretation using forest plots
- How to interpret meta-analysis statistics
- Sub-group analysis
- Identifying tissue-specific biomarkers with an example of cancer subtypes
- Other factors to consider (tumor grade, biological sex, etc)